Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
John Growdon
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Disorders
Anatomy
Concepts & Ideas
Chemicals & Drugs
Physiology
Living Beings
Sign-in to see full Profile
Network (preview)
38
Corkin, Suzanne
31
Hyman, Bradley
23
Nitsch, Roger
16
Myers, Richard
14
Irizarry, Michael
14
Farrer, Lindsay
13
Wurtman, Richard
11
Singer, Carlos
11
Klein, Christine
10
Locascio, Joseph
9
Cronin-Golomb, Alice
8
Binetti, Giuliano
8
Johnson, Keith
8
Haines, Jonathan
8
Rebeck, G. William
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of John Growdon (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Dickerson Bradford C; Bakkour Akram; Salat David H; Feczko Eric; Pacheco Jenni; Greve Douglas N; Grodstein Fran; Wright Christopher I; Blacker Deborah; Rosas H Diana; Sperling Reisa A; Atri Alireza; Growdon John H; Hyman Bradley T; Morris John C; Fischl Bruce; Buckner Randy L
The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals.
Cerebral cortex (New York, N.Y. : 1991) 2009;19(3):497-510.
-
2008: Gomperts S N; Rentz D M; Moran E; Becker J A; Locascio J J; Klunk W E; Mathis C A; Elmaleh D R; Shoup T; Fischman A J; Hyman B T; Growdon J H; Johnson K A
Imaging amyloid deposition in Lewy body diseases.
Neurology 2008;71(12):903-10.
-
2008: McNicoll Christopher F; Latourelle Jeanne C; MacDonald Marcy E; Lew Mark F; Suchowersky Oksana; Klein Christine; Golbe Lawrence I; Mark Margery H; Growdon John H; Wooten G Frederick; Watts Ray L; Guttman Mark; Racette Brad A; Perlmutter Joel S; Ahmed Anwar; Shill Holly A; Singer Carlos; Saint-Hilaire Marie H; Massood Tiffany; Huskey Karen W; DeStefano Anita L; Gillis Tammy; Mysore Jayalakshmi; Goldwurm Stefano; Pezzoli Gianni; Baker Kenneth B; Itin Ilia; Litvan Irene; Nicholson Garth; Corbett Alastair; Nance Martha; Drasby Edward; Isaacson Stuart; Burn David J; Chinnery Patrick F; Pramstaller Peter P; Al-Hinti Jomana; Moller Anette T; Ostergaard Karen; Sherman Scott J; Roxburgh Richard; Snow Barry; Slevin John T; Cambi Franca; Gusella James F; Myers Richard H
Huntington CAG repeat size does not modify onset age in familial Parkinson's disease: the GenePD study.
Movement disorders : official journal of the Movement Disorder Society 2008;23(11):1596-601.
-
2008: DeStefano Anita L; Latourelle Jeanne; Lew Mark F; Suchowersky Oksana; Klein Christine; Golbe Lawrence I; Mark Margery H; Growdon John H; Wooten G Fredrick; Watts Ray; Guttman Mark; Racette Brad A; Perlmutter Joel S; Marlor Lynn; Shill Holly A; Singer Carlos; Goldwurm Stefano; Pezzoli Gianni; Saint-Hilaire Marie H; Hendricks Audrey E; Gower Adam; Williamson Sally; Nagle Michael W; Wilk Jemma B; Massood Tiffany; Huskey Karen W; Baker Kenneth B; Itin Ilia; Litvan Irene; Nicholson Garth; Corbett Alastair; Nance Martha; Drasby Edward; Isaacson Stuart; Burn David J; Chinnery Patrick F; Pramstaller Peter P; Al-Hinti Jomana; Moller Anette T; Ostergaard Karen; Sherman Scott J; Roxburgh Richard; Snow Barry; Slevin John T; Cambi Franca; Gusella James F; Myers Richard H
Replication of association between ELAVL4 and Parkinson disease: the GenePD study.
Human genetics 2008;124(1):95-9.
-
2008: Atri Alireza; Shaughnessy Lynn W; Locascio Joseph J; Growdon John H
Long-term course and effectiveness of combination therapy in Alzheimer disease.
Alzheimer disease and associated disorders 2008;22(3):209-21.
-
2008: Tobin J E; Latourelle J C; Lew M F; Klein C; Suchowersky O; Shill H A; Golbe L I; Mark M H; Growdon J H; Wooten G F; Racette B A; Perlmutter J S; Watts R; Guttman M; Baker K B; Goldwurm S; Pezzoli G; Singer C; Saint-Hilaire M H; Hendricks A E; Williamson S; Nagle M W; Wilk J B; Massood T; Laramie J M; DeStefano A L; Litvan I; Nicholson G; Corbett A; Isaacson S; Burn D J; Chinnery P F; Pramstaller P P; Sherman S; Al-hinti J; Drasby E; Nance M; Moller A T; Ostergaard K; Roxburgh R; Snow B; Slevin J T; Cambi F; Gusella J F; Myers R H
Haplotypes and gene expression implicate the MAPT region for Parkinson disease: the GenePD Study.
Neurology 2008;71(1):28-34.
-
2008: Locascio Joseph J; Fukumoto Hiroaki; Yap Liang; Bottiglieri Teodoro; Growdon John H; Hyman Bradley T; Irizarry Michael C
Plasma amyloid beta-protein and C-reactive protein in relation to the rate of progression of Alzheimer disease.
Archives of neurology 2008;65(6):776-85.
-
2008: Munir Kerim; Coulter Suzanne; Growdon John H; MacDonald Ann; Skerrett Patrick J; Leopold Jane A
How to solve three puzzles.
Newsweek 2008;151(3):64, 66.
-
2008: Freeman Stefanie H; Spires-Jones Tara; Hyman Bradley T; Growdon John H; Frosch Matthew P
TAR-DNA binding protein 43 in Pick disease.
Journal of neuropathology and experimental neurology 2008;67(1):62-7.
-
2008: Patel Shyamal; Hughes Richard; Huggins Nancy; Standaert David; Growdon John; Dy Jennifer; Bonato Paolo
Using wearable sensors to predict the severity of symptoms and motor complications in late stage Parkinson's Disease.
Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Conference 2008;2008():3686-9.
-
2008: Latourelle Jeanne C; Sun Mei; Lew Mark F; Suchowersky Oksana; Klein Christine; Golbe Lawrence I; Mark Margery H; Growdon John H; Wooten G Frederick; Watts Ray L; Guttman Mark; Racette Brad A; Perlmutter Joel S; Ahmed Anwar; Shill Holly A; Singer Carlos; Goldwurm Stefano; Pezzoli Gianni; Zini Michela; Saint-Hilaire Marie H; Hendricks Audrey E; Williamson Sally; Nagle Michael W; Wilk Jemma B; Massood Tiffany; Huskey Karen W; Laramie Jason M; DeStefano Anita L; Baker Kenneth B; Itin Ilia; Litvan Irene; Nicholson Garth; Corbett Alastair; Nance Martha; Drasby Edward; Isaacson Stuart; Burn David J; Chinnery Patrick F; Pramstaller Peter P; Al-hinti Jomana; Moller Anette T; Ostergaard Karen; Sherman Scott J; Roxburgh Richard; Snow Barry; Slevin John T; Cambi Franca; Gusella James F; Myers Richard H
The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD study.
BMC medicine 2008;6():32.
-
2008: Grodstein Francine; van Oijen Marieke; Irizarry Michael C; Rosas H Diana; Hyman Bradley T; Growdon John H; De Vivo Immaculata
Shorter telomeres may mark early risk of dementia: preliminary analysis of 62 participants from the nurses' health study.
PloS one 2008;3(2):e1590.
-
2007: Ingelsson Martin; Ramasamy Karunya; Russ Carsten; Freeman Stefanie H; Orne Jennifer; Raju Susan; Matsui Toshifumi; Growdon John H; Frosch Matthew P; Ghetti Bernardino; Brown Robert H; Irizarry Michael C; Hyman Bradley T
Increase in the relative expression of tau with four microtubule binding repeat regions in frontotemporal lobar degeneration and progressive supranuclear palsy brains.
Acta neuropathologica 2007;114(5):471-9.
-
2007: Lippa C F; Duda J E; Grossman M; Hurtig H I; Aarsland D; Boeve B F; Brooks D J; Dickson D W; Dubois B; Emre M; Fahn S; Farmer J M; Galasko D; Galvin J E; Goetz C G; Growdon J H; Gwinn-Hardy K A; Hardy J; Heutink P; Iwatsubo T; Kosaka K; Lee V M-Y; Leverenz J B; Masliah E; McKeith I G; Nussbaum R L; Olanow C W; Ravina B M; Singleton A B; Tanner C M; Trojanowski J Q; Wszolek Z K;
DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers.
Neurology 2007;68(11):812-9.
-
2007: Bacskai Brian J; Frosch Matthew P; Freeman Stefanie H; Raymond Scott B; Augustinack Jean C; Johnson Keith A; Irizarry Michael C; Klunk William E; Mathis Chester A; Dekosky Steven T; Greenberg Steven M; Hyman Bradley T; Growdon John H
Molecular imaging with Pittsburgh Compound B confirmed at autopsy: a case report.
Archives of neurology 2007;64(3):431-4.
-
2007: Alberici Antonella; Armani Mario; Paterlini Anna; Benussi Luisa; Nicosia Francesca; Ghidoni Roberta; Signorini Simona; Cotelli Maria; Frisoni Giovanni B; Geroldi Cristina; Trevisan Carlo P; Growdon John H; Borroni Barbara; Padovani Alessandro; Rossini Paolo M; Binetti Giuliano
Tau missing from CSF: a case report.
Journal of neurology 2007;254(1):107-9.
-
2007: Scherzer Clemens R; Eklund Aron C; Morse Lee J; Liao Zhixiang; Locascio Joseph J; Fefer Daniel; Schwarzschild Michael A; Schlossmacher Michael G; Hauser Michael A; Vance Jeffery M; Sudarsky Lewis R; Standaert David G; Growdon John H; Jensen Roderick V; Gullans Steven R
Molecular markers of early Parkinson's disease based on gene expression in blood.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(3):955-60.
-
2007: Patel Shyamal; Lorincz Konrad; Hughes Richard; Huggins Nancy; Growdon John H; Welsh Matt; Bonato Paolo
Analysis of feature space for monitoring persons with Parkinson's disease with application to a wireless wearable sensor system.
Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Conference 2007;2007():6291-4.
-
2007: Irizarry M C; Yao Y; Hyman B T; Growdon J H; Praticò D
Plasma F2A isoprostane levels in Alzheimer's and Parkinson's disease.
Neuro-degenerative diseases 2007;4(6):403-5.
-
2006: Wilk J B; Tobin J E; Suchowersky O; Shill H A; Klein C; Wooten G F; Lew M F; Mark M H; Guttman M; Watts R L; Singer C; Growdon J H; Latourelle J C; Saint-Hilaire M H; DeStefano A L; Prakash R; Williamson S; Berg C J; Sun M; Goldwurm S; Pezzoli G; Racette B A; Perlmutter J S; Parsian A; Baker K B; Giroux M L; Litvan I; Pramstaller P P; Nicholson G; Burn D J; Chinnery P F; Vieregge P; Slevin J T; Cambi F; MacDonald M E; Gusella J F; Myers R H; Golbe L I
Herbicide exposure modifies GSTP1 haplotype association to Parkinson onset age: the GenePD Study.
Neurology 2006;67(12):2206-10.
-
2006: Ingelsson Martin; Ramasamy Karunya; Cantuti-Castelvetri Ippolita; Skoglund Lena; Matsui Toshifumi; Orne Jennifer; Kowa Hasimoto; Raju Susan; Vanderburg Charles R; Augustinack Jean C; de Silva Rohan; Lees Andrew J; Lannfelt Lars; Growdon John H; Frosch Matthew P; Standaert David G; Irizarry Michael C; Hyman Bradley T
No alteration in tau exon 10 alternative splicing in tangle-bearing neurons of the Alzheimer's disease brain.
Acta neuropathologica 2006;112(4):439-49.
-
2006: Hyman Bradley T; Growdon John H
Can the immune system fight Alzheimer disease?
Nature medicine 2006;12(7):755-6; discussion 756.
-
2006: Sun Mei; Latourelle Jeanne C; Wooten G Frederick; Lew Mark F; Klein Christine; Shill Holly A; Golbe Lawrence I; Mark Margery H; Racette Brad A; Perlmutter Joel S; Parsian Abbas; Guttman Mark; Nicholson Garth; Xu Gang; Wilk Jemma B; Saint-Hilaire Marie H; DeStefano Anita L; Prakash Ranjana; Williamson Sally; Suchowersky Oksana; Labelle Nancy; Growdon John H; Singer Carlos; Watts Ray L; Goldwurm Stefano; Pezzoli Gianni; Baker Kenneth B; Pramstaller Peter P; Burn David J; Chinnery Patrick F; Sherman Scott; Vieregge Peter; Litvan Irene; Gillis Tammy; MacDonald Marcy E; Myers Richard H; Gusella James F
Influence of heterozygosity for parkin mutation on onset age in familial Parkinson disease: the GenePD study.
Archives of neurology 2006;63(6):826-32.
-
2006: Klucken J; Ingelsson M; Shin Y; Irizarry M C; Hedley-Whyte E T; Frosch M; Growdon J; McLean Pamela; Hyman Bradley T
Clinical and biochemical correlates of insoluble alpha-synuclein in dementia with Lewy bodies.
Acta neuropathologica 2006;111(2):101-8.
-
2006: Gurol M E; Irizarry M C; Smith E E; Raju S; Diaz-Arrastia R; Bottiglieri T; Rosand J; Growdon J H; Greenberg S M
Plasma beta-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy.
Neurology 2006;66(1):23-9.
-
2006: Lleó A; Greenberg S M; Growdon J H
Current pharmacotherapy for Alzheimer's disease.
Annual review of medicine 2006;57():513-33.
-
2005: Irizarry M C; Gurol M E; Raju S; Diaz-Arrastia R; Locascio J J; Tennis M; Hyman B T; Growdon J H; Greenberg S M; Bottiglieri T
Association of homocysteine with plasma amyloid beta protein in aging and neurodegenerative disease.
Neurology 2005;65(9):1402-8.
-
2005: Growdon John H
Commentary on "Diagnosis of Alzheimer's disease: Two decades of progress." The NIA's Alzheimer Disease Centers.
Alzheimer's & dementia : the journal of the Alzheimer's Association 2005;1(2):101.
-
2005: Karamohamed Samer; Golbe L I; Mark M H; Lazzarini A M; Suchowersky O; Labelle N; Guttman Mark; Currie L J; Wooten G F; Stacy M; Saint-Hilaire M; Feldman R G; Liu J; Shoemaker C M; Wilk J B; DeStefano A L; Latourelle J C; Xu G; Watts R; Growdon J; Lew M; Waters C; Vieregge P; Pramstaller P P; Klein C; Racette B A; Perlmutter J S; Parsian A; Singer Carlos; Montgomery E; Baker K; Gusella J F; Herbert A; Myers R H
Absence of previously reported variants in the SCNA (G88C and G209A), NR4A2 (T291D and T245G) and the DJ-1 (T497C) genes in familial Parkinson's disease from the GenePD study.
Movement disorders : official journal of the Movement Disorder Society 2005;20(9):1188-91.
-
2005: Atri Alireza; Locascio Joseph J; Lin Jenny M; Yap Liang; Dickerson Bradford C; Grodstein Francine; Irizarry Michael C; Growdon John H; Greenberg S M
Prevalence and effects of lobar microhemorrhages in early-stage dementia.
Neuro-degenerative diseases 2005;2(6):305-12.
-
2004: Alberici A; Gobbo C; Panzacchi A; Nicosia F; Ghidoni R; Benussi L; Hock C; Papassotiropoulos A; Liberini P; Growdon J H; Frisoni G B; Villa A; Zanetti O; Cappa S; Fazio F; Binetti G
Frontotemporal dementia: impact of P301L tau mutation on a healthy carrier.
Journal of neurology, neurosurgery, and psychiatry 2004;75(11):1607-10.
-
2004: Ingelsson M; Fukumoto H; Newell K L; Growdon J H; Hedley-Whyte E T; Frosch M P; Albert M S; Hyman B T; Irizarry M C
Early Abeta accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain.
Neurology 2004;62(6):925-31.
-
2004: Lleó Alberto; Berezovska Oksana; Growdon John H; Hyman Bradley T
Clinical, pathological, and biochemical spectrum of Alzheimer disease associated with PS-1 mutations.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2004;12(2):146-56.
-
2004: Kensinger Elizabeth A; Anderson Alberta; Growdon John H; Corkin Suzanne
Effects of Alzheimer disease on memory for verbal emotional information.
Neuropsychologia 2004;42(6):791-800.
-
2003: Karamohamed S; DeStefano A L; Wilk J B; Shoemaker C M; Golbe L I; Mark M H; Lazzarini A M; Suchowersky O; Labelle N; Guttman M; Currie L J; Wooten G F; Stacy M; Saint-Hilaire M; Feldman R G; Sullivan K M; Xu G; Watts R; Growdon J; Lew M; Waters C; Vieregge P; Pramstaller P P; Klein C; Racette B A; Perlmutter J S; Parsian A; Singer C; Montgomery E; Baker K; Gusella J F; Fink S J; Myers R H; Herbert A;
A haplotype at the PARK3 locus influences onset age for Parkinson's disease: the GenePD study.
Neurology 2003;61(11):1557-61.
-
2003: Fukumoto Hiroaki; Tennis Marsha; Locascio Joseph J; Hyman Bradley T; Growdon John H; Irizarry Michael C
Age but not diagnosis is the main predictor of plasma amyloid beta-protein levels.
Archives of neurology 2003;60(7):958-64.
-
2003: Zhukareva Victoria; Sundarraj Sonali; Mann David; Sjogren Magnus; Blenow Kaj; Clark Christopher M; McKeel Daniel W; Goate Alison; Lippa Carol F; Vonsattel Jean-Paul; Growdon John H; Trojanowski John Q; Lee Virginia M-Y
Selective reduction of soluble tau proteins in sporadic and familial frontotemporal dementias: an international follow-up study.
Acta neuropathologica 2003;105(5):469-76.
-
2003: Kensinger Elizabeth A; Shearer Deirdre K; Locascio Joseph J; Growdon John H; Corkin Suzanne
Working memory in mild Alzheimer's disease and early Parkinson's disease.
Neuropsychology 2003;17(2):230-9.
-
2003: Locascio Joseph J; Corkin Suzanne; Growdon John H
Relation between clinical characteristics of Parkinson's disease and cognitive decline.
Journal of clinical and experimental neuropsychology 2003;25(1):94-109.
-
2002: Kensinger Elizabeth A; Brierley Barbara; Medford Nick; Growdon John H; Corkin Suzanne
Effects of normal aging and Alzheimer's disease on emotional memory.
Emotion (Washington, D.C.) 2002;2(2):118-34.
-
2002: DeStefano Anita L; Lew Mark F; Golbe Lawrence I; Mark Margery H; Lazzarini Alice M; Guttman Mark; Montgomery Erwin; Waters Cheryl H; Singer Carlos; Watts Ray L; Currie Lillian J; Wooten G Frederick; Maher Nancy E; Wilk Jemma B; Sullivan Kristin M; Slater Karen M; Saint-Hilaire Marie H; Feldman Robert G; Suchowersky Oksana; Lafontaine Anne-Louise; Labelle Nancy; Growdon John H; Vieregge Peter; Pramstaller Peter P; Klein Christine; Hubble Jean P; Reider Carson R; Stacy Mark; MacDonald Marcy E; Gusella James F; Myers Richard H
PARK3 influences age at onset in Parkinson disease: a genome scan in the GenePD study.
American journal of human genetics 2002;70(5):1089-95.
-
2002: Pompeu Fernando; Growdon John H
Diagnosing dementia with Lewy bodies.
Archives of neurology 2002;59(1):29-30.
-
2002: Maher N E; Golbe L I; Lazzarini A M; Mark M H; Currie L J; Wooten G F; Saint-Hilaire M; Wilk J B; Volcjak J; Maher J E; Feldman R G; Guttman M; Lew M; Waters C H; Schuman S; Suchowersky O; Lafontaine A L; Labelle N; Vieregge P; Pramstaller P P; Klein C; Hubble J; Reider C; Growdon J; Watts R; Montgomery E; Baker K; Singer C; Stacy M; Myers R H
Epidemiologic study of 203 sibling pairs with Parkinson's disease: the GenePD study.
Neurology 2002;58(1):79-84.
-
2001: DeStefano A L; Golbe L I; Mark M H; Lazzarini A M; Maher N E; Saint-Hilaire M; Feldman R G; Guttman M; Watts R L; Suchowersky O; Lafontaine A L; Labelle N; Lew M F; Waters C H; Growdon J H; Singer C; Currie L J; Wooten G F; Vieregge P; Pramstaller P P; Klein C; Hubble J P; Stacy M; Montgomery E; MacDonald M E; Gusella J F; Myers R H
Genome-wide scan for Parkinson's disease: the GenePD Study.
Neurology 2001;57(6):1124-6.
-
2001: Deng A; Irizarry M C; Nitsch R M; Growdon J H; Rebeck G W
Elevation of cystatin C in susceptible neurons in Alzheimer's disease.
The American journal of pathology 2001;159(3):1061-8.
-
2000: Nitsch R M; Deng M; Tennis M; Schoenfeld D; Growdon J H
The selective muscarinic M1 agonist AF102B decreases levels of total Abeta in cerebrospinal fluid of patients with Alzheimer's disease.
Annals of neurology 2000;48(6):913-8.
-
2000: Finckh U; von der Kammer H; Velden J; Michel T; Andresen B; Deng A; Zhang J; Müller-Thomsen T; Zuchowski K; Menzer G; Mann U; Papassotiropoulos A; Heun R; Zurdel J; Holst F; Benussi L; Stoppe G; Reiss J; Miserez A R; Staehelin H B; Rebeck G W; Hyman B T; Binetti G; Hock C; Growdon J H; Nitsch R M
Genetic association of a cystatin C gene polymorphism with late-onset Alzheimer disease.
Archives of neurology 2000;57(11):1579-83.
-
2000: Growdon W; Ghika J; Henderson J; van Melle G; Regli F; Bogousslavsky J; Growdon J H
Effects of proximal and distal muscles' groups contraction and mental stress on the amplitude and frequency of physiological finger tremor. An accelerometric study.
Electromyography and clinical neurophysiology 2000;40(5):295-303.
-
2000: Guo Z; Cupples L A; Kurz A; Auerbach S H; Volicer L; Chui H; Green R C; Sadovnick A D; Duara R; DeCarli C; Johnson K; Go R C; Growdon J H; Haines J L; Kukull W A; Farrer L A
Head injury and the risk of AD in the MIRAGE study.
Neurology 2000;54(6):1316-23.
-
2000: Binetti G; Locascio J J; Corkin S; Vonsattel J P; Growdon J H
Differences between Pick disease and Alzheimer disease in clinical appearance and rate of cognitive decline.
Archives of neurology 2000;57(2):225-32.
-
2000: Greenberg S M; Tennis M K; Brown L B; Gomez-Isla T; Hayden D L; Schoenfeld D A; Walsh K L; Corwin C; Daffner K R; Friedman P; Meadows M E; Sperling R A; Growdon J H
Donepezil therapy in clinical practice: a randomized crossover study.
Archives of neurology 2000;57(1):94-9.
-
2000: Hock C; Maddalena A; Heuser I; Naber D; Oertel W; von der Kammer H; Wienrich M; Raschig A; Deng M; Growdon J H; Nitsch R M
Treatment with the selective muscarinic agonist talsaclidine decreases cerebrospinal fluid levels of total amyloid beta-peptide in patients with Alzheimer's disease.
Annals of the New York Academy of Sciences 2000;920():285-91.
-
2000: Ellis T; Cudkowicz M E; Sexton P M; Growdon J H
Clozapine and risperidone treatment of psychosis in Parkinson's disease.
The Journal of neuropsychiatry and clinical neurosciences 2000;12(3):364-9.
-
1999: Newell K L; Hyman B T; Growdon J H; Hedley-Whyte E T
Application of the National Institute on Aging (NIA)-Reagan Institute criteria for the neuropathological diagnosis of Alzheimer disease.
Journal of neuropathology and experimental neurology 1999;58(11):1147-55.
-
1999: Gómez-Tortosa E; Newell K; Irizarry M C; Albert M; Growdon J H; Hyman B T
Clinical and quantitative pathologic correlates of dementia with Lewy bodies.
Neurology 1999;53(6):1284-91.
-
1999: Alberici A; Moratto D; Benussi L; Gasparini L; Ghidoni R; Gatta L B; Finazzi D; Frisoni G B; Trabucchi M; Growdon J H; Nitsch R M; Binetti G
Presenilin 1 protein directly interacts with Bcl-2.
The Journal of biological chemistry 1999;274(43):30764-9.
-
1999: Solomon P R; Adams F A; Groccia M E; DeVeaux R; Growdon J H; Pendlebury W W
Correlational analysis of five commonly used measures of mental status/functional abilities in patients with Alzheimer disease.
Alzheimer disease and associated disorders 1999;13(3):147-50.
-
1999: Growdon J H
Biomarkers of Alzheimer disease.
Archives of neurology 1999;56(3):281-3.
-
1999: Gasparini L; Ghidoni R; Alberici A C; Benussi L; Moratto D; Trabucchi M; Growdon J H; Nitsch R M; Binetti G
Modulation of presenilin-1 processing by nitric oxide during apoptosis induced by serum withdrawal and glucose deprivation.
Annals of the New York Academy of Sciences 1999;893():294-7.
-
1999: Irizarry M C; Ghaemi S N; Lee-Cherry E R; Gomez-Isla T; Binetti G; Hyman B T; Growdon J H
Risperidone treatment of behavioral disturbances in outpatients with dementia.
The Journal of neuropsychiatry and clinical neurosciences 1999;11(3):336-42.
-
1998: Liao A; Nitsch R M; Greenberg S M; Finckh U; Blacker D; Albert M; Rebeck G W; Gomez-Isla T; Clatworthy A; Binetti G; Hock C; Mueller-Thomsen T; Mann U; Zuchowski K; Beisiegel U; Staehelin H; Growdon J H; Tanzi R E; Hyman B T
Genetic association of an alpha2-macroglobulin (Val1000lle) polymorphism and Alzheimer's disease.
Human molecular genetics 1998;7(12):1953-6.
-
1998: Growdon J H
Apolipoprotein E and Alzheimer disease.
Archives of neurology 1998;55(8):1053-4.
-
1998: Growdon J H
To tap or not to tap: cerebrospinal fluid biomarkers of Alzheimer's disease.
Annals of neurology 1998;44(1):6-7.
-
1998: Trojanowski J Q; Growdon J H
A new consensus report on biomarkers for the early antemortem diagnosis of Alzheimer disease: current status, relevance to drug discovery, and recommendations for future research.
Journal of neuropathology and experimental neurology 1998;57(6):643-4.
-
1998: Growdon J H; Kieburtz K; McDermott M P; Panisset M; Friedman J H
Levodopa improves motor function without impairing cognition in mild non-demented Parkinson's disease patients. Parkinson Study Group.
Neurology 1998;50(5):1327-31.
-
1998: Nitsch R M; Kim C; Growdon J H
Vasopressin and bradykinin regulate secretory processing of the amyloid protein precursor of Alzheimer's disease.
Neurochemical research 1998;23(5):807-14.
-
1998: Silver M; Newell K; Hyman B; Growdon J; Hedley-Whyte E T; Perls T
Unraveling the mystery of cognitive changes in old age: correlation of neuropsychological evaluation with neuropathological findings in the extreme old.
International psychogeriatrics / IPA 1998;10(1):25-41.
-
1998: Rebeck G W; Alonzo N C; Berezovska O; Harr S D; Knowles R B; Growdon J H; Hyman B T; Mendez A J
Structure and functions of human cerebrospinal fluid lipoproteins from individuals of different APOE genotypes.
Experimental neurology 1998;149(1):175-82.
-
1998: Hock C; Drasch G; Golombowski S; Müller-Spahn F; Willershausen-Zönnchen B; Schwarz P; Hock U; Growdon J H; Nitsch R M
Increased blood mercury levels in patients with Alzheimer's disease.
Journal of neural transmission (Vienna, Austria : 1996) 1998;105(1):59-68.
-
1998: Hock C; Golombowski S; Müller-Spahn F; Naser W; Beyreuther K; Mönning U; Schenk D; Vigo-Pelfrey C; Bush A M; Moir R; Tanzi R E; Growdon J H; Nitsch R M
Cerebrospinal fluid levels of amyloid precursor protein and amyloid beta-peptide in Alzheimer's disease and major depression - inverse correlation with dementia severity.
European neurology 1998;39(2):111-8.
-
1997: Postle B R; Locascio J J; Corkin S; Growdon J H
The time course of spatial and object learning in Parkinson's disease.
Neuropsychologia 1997;35(10):1413-22.
-
1997: Scott W K; Saunders A M; Gaskell P C; Locke P A; Growdon J H; Farrer L A; Auerbach S A; Roses A D; Haines J L; Pericak-Vance M A
Apolipoprotein E epsilon2 does not increase risk of early-onset sporadic Alzheimer's disease.
Annals of neurology 1997;42(3):376-8.
-
1997: Nitsch R M; Deng A; Wurtman R J; Growdon J H
Metabotropic glutamate receptor subtype mGluR1alpha stimulates the secretion of the amyloid beta-protein precursor ectodomain.
Journal of neurochemistry 1997;69(2):704-12.
-
1997: Growdon J H; Graefe K; Tennis M; Hayden D; Schoenfeld D; Wray S H
Pupil dilation to tropicamide is not specific for Alzheimer disease.
Archives of neurology 1997;54(7):841-4.
-
1997: Gómez-Isla T; Wasco W; Pettingell W P; Gurubhagavatula S; Schmidt S D; Jondro P D; McNamara M; Rodes L A; DiBlasi T; Growdon W B; Seubert P; Schenk D; Growdon J H; Hyman B T; Tanzi R E
A novel presenilin-1 mutation: increased beta-amyloid and neurofibrillary changes.
Annals of neurology 1997;41(6):809-13.
-
1997: Sano M; Ernesto C; Thomas R G; Klauber M R; Schafer K; Grundman M; Woodbury P; Growdon J; Cotman C W; Pfeiffer E; Schneider L S; Thal L J
A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study.
The New England journal of medicine 1997;336(17):1216-22.
-
1997: Postle B R; Jonides J; Smith E E; Corkin S; Growdon J H
Spatial, but not object, delayed response is impaired in early Parkinson's disease.
Neuropsychology 1997;11(2):171-9.
-
1997: Gómez-Isla T; Hollister R; West H; Mui S; Growdon J H; Petersen R C; Parisi J E; Hyman B T
Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease.
Annals of neurology 1997;41(1):17-24.
-
1997: Scott W K; Yamaoka L H; Locke P A; Rosi B L; Gaskell P C; Saunders A M; Conneally P M; Small G W; Farrer L A; Growdon J H; Roses A D; Pericak-Vance M A; Haines J L
No association or linkage between an intronic polymorphism of presenilin-1 and sporadic or late-onset familial Alzheimer disease.
Genetic epidemiology 1997;14(3):307-15.
-
1997: Growdon J H
Muscarinic agonists in Alzheimer's disease.
Life sciences 1997;60(13-14):993-8.
-
1996: Haines J L; Pritchard M L; Saunders A M; Schildkraut J M; Growdon J H; Gaskell P C; Farrer L A; Auerbach S A; Gusella J F; Locke P A; Rosi B L; Yamaoka L; Small G W; Conneally P M; Roses A D; Pericak-Vance M
No association between alpha 1-antichymotrypsin and familial Alzheimer's disease.
Annals of the New York Academy of Sciences 1996;802():35-41.
-
1996: Hyman B T; Gomez-Isla T; Rebeck G W; Briggs M; Chung H; West H L; Greenberg S; Mui S; Nichols S; Wallace R; Growdon J H
Epidemiological, clinical, and neuropathological study of apolipoprotein E genotype in Alzheimer's disease.
Annals of the New York Academy of Sciences 1996;802():1-5.
-
1996: Postle B R; Corkin S; Growdon J H
Intact implicit memory for novel patterns in Alzheimer's disease.
Learning & memory (Cold Spring Harbor, N.Y.) 1996;3(4):305-12.
-
1996: Rao V S; Cupples A; van Duijn C M; Kurz A; Green R C; Chui H; Duara R; Auerbach S A; Volicer L; Wells J; van Broeckhoven C; Growdon J H; Haines J L; Farrer L A
Evidence for major gene inheritance of Alzheimer disease in families of patients with and without apolipoprotein E epsilon 4.
American journal of human genetics 1996;59(3):664-75.
-
1996: Growdon J H; Locascio J J; Corkin S; Gomez-Isla T; Hyman B T
Apolipoprotein E genotype does not influence rates of cognitive decline in Alzheimer's disease.
Neurology 1996;47(2):444-8.
-
1996: Litvan I; Agid Y; Calne D; Campbell G; Dubois B; Duvoisin R C; Goetz C G; Golbe L I; Grafman J; Growdon J H; Hallett M; Jankovic J; Quinn N P; Tolosa E; Zee D S
Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop.
Neurology 1996;47(1):1-9.
-
1996: Gómez-Isla T; Price J L; McKeel D W; Morris J C; Growdon J H; Hyman B T
Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1996;16(14):4491-500.
-
1996: Haines J L; Pritchard M L; Saunders A M; Schildkraut J M; Growdon J H; Gaskell P C; Farrer L A; Auerbach S A; Gusella J F; Locke P A; Rosi B L; Yamaoka L; Small G W; Conneally P M; Roses A D; Pericak-Vance M A
No genetic effect of alpha1-antichymotrypsin in Alzheimer disease.
Genomics 1996;33(1):53-6.
-
1996: Scott W K; Growdon J H; Roses A D; Haines J L; Pericak-Vance M A
Presenilin-1 polymorphism and Alzheimer's disease.
Lancet 1996;347(9009):1186-7.
-
1996: Hyman B T; Hedley-Whyte E T; Rebeck G W; Vonsattel J P; West H L; Growdon J H
Apolipoprotein E epsilon4/4 in a neuropathologically normal very elderly individual.
Archives of neurology 1996;53(3):215.
-
1996: Lautenschlager N T; Cupples L A; Rao V S; Auerbach S A; Becker R; Burke J; Chui H; Duara R; Foley E J; Glatt S L; Green R C; Jones R; Karlinsky H; Kukull W A; Kurz A; Larson E B; Martelli K; Sadovnick A D; Volicer L; Waring S C; Growdon J H; Farrer L A
Risk of dementia among relatives of Alzheimer's disease patients in the MIRAGE study: What is in store for the oldest old?
Neurology 1996;46(3):641-50.
-
1996: Nitsch R M; Deng M; Growdon J H; Wurtman R J
Serotonin 5-HT2a and 5-HT2c receptors stimulate amyloid precursor protein ectodomain secretion.
The Journal of biological chemistry 1996;271(8):4188-94.
-
1996: Nitsch R M; Wurtman R J; Growdon J H
Regulation of APP processing. Potential for the therapeutical reduction of brain amyloid burden.
Annals of the New York Academy of Sciences 1996;777():175-82.
-
1996: Hyman B T; Gomez-Isla T; West H; Briggs M; Chung H; Growdon J H; Rebeck G W
Clinical and neuropathological correlates of apolipoprotein E genotype in Alzheimer's disease. Window on molecular epidemiology.
Annals of the New York Academy of Sciences 1996;777():158-65.
-
1996: Gomez-Isla T; West H L; Rebeck G W; Harr S D; Growdon J H; Locascio J J; Perls T T; Lipsitz L A; Hyman B T
Clinical and pathological correlates of apolipoprotein E epsilon 4 in Alzheimer's disease.
Annals of neurology 1996;39(1):62-70.
-
1996: Gonzalez R G; Guimaraes A R; Moore G J; Crawley A; Cupples L A; Growdon J H
Quantitative in vivo 31P magnetic resonance spectroscopy of Alzheimer disease.
Alzheimer disease and associated disorders 1996;10(1):46-52.
-
1996: Sano M; Ernesto C; Klauber M R; Schafer K; Woodbury P; Thomas R; Grundman M; Growdon J; Thal L J
Rationale and design of a multicenter study of selegiline and alpha-tocopherol in the treatment of Alzheimer disease using novel clinical outcomes. Alzheimer's Disease Cooperative Study.
Alzheimer disease and associated disorders 1996;10(3):132-40.
-
1995: Locascio J J; Growdon J H; Corkin S
Cognitive test performance in detecting, staging, and tracking Alzheimer's disease.
Archives of neurology 1995;52(11):1087-99.
-
1995: González R G; Fischman A J; Guimaraes A R; Carr C A; Stern C E; Halpern E F; Growdon J H; Rosen B R
Functional MR in the evaluation of dementia: correlation of abnormal dynamic cerebral blood volume measurements with changes in cerebral metabolism on positron emission tomography with fludeoxyglucose F 18.
AJNR. American journal of neuroradiology 1995;16(9):1763-70.
-
1995: Farrer L A; Cupples L A; van Duijn C M; Connor-Lacke L; Kiely D K; Growdon J H
Rate of progression of Alzheimer's disease is associated with genetic risk.
Archives of neurology 1995;52(9):918-23.
-
1995: Ghika J; Tennis M; Growdon J; Hoffman E; Johnson K
Environment-driven responses in progressive supranuclear palsy.
Journal of the neurological sciences 1995;130(1):104-11.
-
1995: Nitsch R M; Wurtman R J; Growdon J H
Regulation of proteolytic processing of the amyloid beta-protein precursor by first messengers. A novel potential approach for the treatment of Alzheimer's disease.
Arzneimittel-Forschung 1995;45(3A):435-8.
-
1995: Cronin-Golomb A; Corkin S; Growdon J H
Visual dysfunction predicts cognitive deficits in Alzheimer's disease.
Optometry and vision science : official publication of the American Academy of Optometry 1995;72(3):168-76.
-
1995: Mendola J D; Cronin-Golomb A; Corkin S; Growdon J H
Prevalence of visual deficits in Alzheimer's disease.
Optometry and vision science : official publication of the American Academy of Optometry 1995;72(3):155-67.
-
1994: Kurylo D D; Corkin S; Growdon J H
Perceptual organization in Alzheimer's disease.
Psychology and aging 1994;9(4):562-7.
-
1994: Rao V S; van Duijn C M; Connor-Lacke L; Cupples L A; Growdon J H; Farrer L A
Multiple etiologies for Alzheimer disease are revealed by segregation analysis.
American journal of human genetics 1994;55(5):991-1000.
-
1994: Kieburtz K; McDermott M; Como P; Growdon J; Brady J; Carter J; Huber S; Kanigan B; Landow E; Rudolph A
The effect of deprenyl and tocopherol on cognitive performance in early untreated Parkinson's disease. Parkinson Study Group.
Neurology 1994;44(9):1756-9.
-
1994: Cronin-Golomb A; Corkin S; Growdon J H
Impaired problem solving in Parkinson's disease: impact of a set-shifting deficit.
Neuropsychologia 1994;32(5):579-93.
-
1994: Kurylo D D; Corkin S; Dolan R P; Rizzo J F; Parker S W; Growdon J H
Broad-band visual capacities are not selectively impaired in Alzheimer's disease.
Neurobiology of aging 1994;15(3):305-11.
-
1994: Farrer L A; Cupples L A; Blackburn S; Kiely D K; Auerbach S; Growdon J H; Connor-Lacke L; Karlinsky H; Thibert A; Burke J R
Interrater agreement for diagnosis of Alzheimer's disease: the MIRAGE study.
Neurology 1994;44(4):652-6.
-
1994: Nitsch R M; Growdon J H
Role of neurotransmission in the regulation of amyloid beta-protein precursor processing.
Biochemical pharmacology 1994;47(8):1275-84.
-
1994: Keane M M; Gabrieli J D; Growdon J H; Corkin S
Priming in perceptual identification of pseudowords is normal in Alzheimer's disease.
Neuropsychologia 1994;32(3):343-56.
-
1994: Gabrieli J D; Keane M M; Stanger B Z; Kjelgaard M M; Corkin S; Growdon J H
Dissociations among structural-perceptual, lexical-semantic, and event-fact memory systems in Alzheimer, amnesic, and normal subjects.
Cortex; a journal devoted to the study of the nervous system and behavior 1994;30(1):75-103.
-
1994: Cole D G; Growdon J H
Therapy for progressive supranuclear palsy: past and future.
Journal of neural transmission. Supplementum 1994;42():283-90.
-
1994: Nitsch R M; Slack B E; Farber S A; Schulz J G; Deng M; Kim C; Borghesani P R; Korver W; Wurtman R J; Growdon J H
Regulation of proteolytic processing of the amyloid beta-protein precursor of Alzheimer's disease in transfected cell lines and in brain slices.
Journal of neural transmission. Supplementum 1994;44():21-7.
-
1993: Gabrieli J D; Corkin S; Mickel S F; Growdon J H
Intact acquisition and long-term retention of mirror-tracing skill in Alzheimer's disease and in global amnesia.
Behavioral neuroscience 1993;107(6):899-910.
-
1993: Hung A Y; Haass C; Nitsch R M; Qiu W Q; Citron M; Wurtman R J; Growdon J H; Selkoe D J
Activation of protein kinase C inhibits cellular production of the amyloid beta-protein.
The Journal of biological chemistry 1993;268(31):22959-62.
-
1993: Kurylo D D; Corkin S; Allard T; Zatorre R J; Growdon J H
Auditory function in Alzheimer's disease.
Neurology 1993;43(10):1893-9.
-
1993: Nitsch R M; Blusztajn J K; Doyle F M; Robitaille Y; Wurtman R J; Growdon J H; Kish S J
Phospholipid metabolite levels are altered in cerebral cortex of patients with dominantly inherited olivopontocerebellar atrophy.
Neuroscience letters 1993;161(2):191-4.
-
1993: Cronin-Golomb A; Sugiura R; Corkin S; Growdon J H
Incomplete achromatopsia in Alzheimer's disease.
Neurobiology of aging 1993;14(5):471-7.
-
1993: Nitsch R M; Slack B E; Farber S A; Borghesani P R; Schulz J G; Kim C; Felder C C; Growdon J H; Wurtman R J
Receptor-coupled amyloid precursor protein processing.
Annals of the New York Academy of Sciences 1993;695():122-7.
-
1993: Borgaonkar D S; Schmidt L C; Martin S E; Kanzer M D; Edelsohn L; Growdon J; Farrer L A
Linkage of late-onset Alzheimer's disease with apolipoprotein E type 4 on chromosome 19.
Lancet 1993;342(8871):625.
-
1993: Nitsch R M; Farber S A; Growdon J H; Wurtman R J
Release of amyloid beta-protein precursor derivatives by electrical depolarization of rat hippocampal slices.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(11):5191-3.
-
1993: Ghika J; Regli F; Growdon J H
Sensory symptoms in cranial dystonia: a potential role in the etiology?
Journal of the neurological sciences 1993;116(2):142-7.
-
1993: Cole D G; Growdon J H; DiFiglia M
Levodopa induction of Fos immunoreactivity in rat brain following partial and complete lesions of the substantia nigra.
Experimental neurology 1993;120(2):223-32.
-
1993: Kischka U; Mandir A S; Ghika J; Growdon J H
Electrophysiologic detection of extrapyramidal motor signs in Alzheimer's disease.
Neurology 1993;43(3 Pt 1):500-5.
-
1993: Ghika J; Wiegner A W; Fang J J; Davies L; Young R R; Growdon J H
Portable system for quantifying motor abnormalities in Parkinson's disease.
IEEE transactions on bio-medical engineering 1993;40(3):276-83.
-
1993: Du W; DiLuca C; Growdon J H
Weight loss in Alzheimer's disease.
Journal of geriatric psychiatry and neurology 1993;6(1):34-8.
-
1993: Pericak-Vance M A; St George-Hyslop P H; Gaskell P C; Growdon J; Crain B J; Hulette C; Gusella J F; Yamaoka L; Tanzi R E; Roses A D
Linkage analysis in familial Alzheimer disease: description of the Duke and Boston data sets.
Genetic epidemiology 1993;10(6):361-4.
-
1992: Huff E J; Growdon J H; Corkin S
Deterioration on the Blessed Information-Memory-Concentration Test in Alzheimer's disease.
Psychiatry research 1992;44(2):167-8.
-
1992: Nitsch R M; Slack B E; Wurtman R J; Growdon J H
Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors.
Science (New York, N.Y.) 1992;258(5080):304-7.
-
1992: Growdon J H
Treatment for Alzheimer's disease?
The New England journal of medicine 1992;327(18):1306-8.
-
1992: Hauser S L; Doolittle T H; Lopez-Bresnahan M; Shahani B; Schoenfeld D; Shih V E; Growdon J; Lehrich J R
An antispasticity effect of threonine in multiple sclerosis.
Archives of neurology 1992;49(9):923-6.
-
1992: Cronin-Golomb A; Keane M M; Kokodis A; Corkin S; Growdon J H
Category knowledge in Alzheimer's disease: normal organization and a general retrieval deficit.
Psychology and aging 1992;7(3):359-66.
-
1992: Johnson K A; Sperling R A; Holman B L; Nagel J S; Growdon J H
Cerebral perfusion in progressive supranuclear palsy.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1992;33(5):704-9.
-
1992: Arriagada P V; Growdon J H; Hedley-Whyte E T; Hyman B T
Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease.
Neurology 1992;42(3 Pt 1):631-9.
-
1992: Nitsch R M; Blusztajn J K; Pittas A G; Slack B E; Growdon J H; Wurtman R J
Evidence for a membrane defect in Alzheimer disease brain.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(5):1671-5.
-
1992: Rizzo J F; Cronin-Golomb A; Growdon J H; Corkin S; Rosen T J; Sandberg M A; Chiappa K H; Lessell S
Retinocalcarine function in Alzheimer's disease. A clinical and electrophysiological study.
Archives of neurology 1992;49(1):93-101.
-
1991: Growdon J H; Nader T M; Schoenfeld J; Wurtman R J
L-threonine in the treatment of spasticity.
Clinical neuropharmacology 1991;14(5):403-12.
-
1991: Berry E M; Growdon J H; Wurtman J J; Caballero B; Wurtman R J
A balanced carbohydrate: protein diet in the management of Parkinson's disease.
Neurology 1991;41(8):1295-7.
-
1991: Ghika J; Tennis M; Hoffman E; Schoenfeld D; Growdon J
Idazoxan treatment in progressive supranuclear palsy.
Neurology 1991;41(7):986-91.
-
1991: Farrer L A; Cupples L A; Connor L; Wolf P A; Growdon J H
Association of decreased paternal age and late-onset Alzheimer's disease. An example of genetic imprinting?
Archives of neurology 1991;48(6):599-604.
-
1991: Farrer L A; Myers R H; Connor L; Cupples L A; Growdon J H
Segregation analysis reveals evidence of a major gene for Alzheimer disease.
American journal of human genetics 1991;48(6):1026-33.
-
1991: Keane M M; Gabrieli J D; Fennema A C; Growdon J H; Corkin S
Evidence for a dissociation between perceptual and conceptual priming in Alzheimer's disease.
Behavioral neuroscience 1991;105(2):326-42.
-
1991: Cronin-Golomb A; Corkin S; Rizzo J F; Cohen J; Growdon J H; Banks K S
Visual dysfunction in Alzheimer's disease: relation to normal aging.
Annals of neurology 1991;29(1):41-52.
-
1991: Cronin-Golomb A; Rizzo J F; Corkin S; Growdon J H
Visual function in Alzheimer's disease and normal aging.
Annals of the New York Academy of Sciences 1991;640():28-35.
-
1991: Nitsch R; Pittas A; Blusztajn J K; Slack B E; Growdon J H; Wurtman R J
Alterations of phospholipid metabolites in postmortem brain from patients with Alzheimer's disease.
Annals of the New York Academy of Sciences 1991;640():110-3.
-
1990: Blusztajn J K; Lopez Gonzalez-Coviella I; Logue M; Growdon J H; Wurtman R J
Levels of phospholipid catabolic intermediates, glycerophosphocholine and glycerophosphoethanolamine, are elevated in brains of Alzheimer's disease but not of Down's syndrome patients.
Brain research 1990;536(1-2):240-4.
-
1990: Johnson K A; Holman B L; Rosen T J; Nagel J S; English R J; Growdon J H
Iofetamine I 123 single photon emission computed tomography is accurate in the diagnosis of Alzheimer's disease.
Archives of internal medicine 1990;150(4):752-6.
-
1990: Wurtman R J; Blusztajn J K; Ulus I H; Coviella I L; Buyukuysal R L; Growdon J H; Slack B E
Choline metabolism in cholinergic neurons: implications for the pathogenesis of neurodegenerative diseases.
Advances in neurology 1990;51():117-25.
-
1990: Growdon J H; Corkin S; Rosen T J
Distinctive aspects of cognitive dysfunction in Parkinson's disease.
Advances in neurology 1990;53():365-76.
-
1989: Sullivan E V; Sagar H J; Gabrieli J D; Corkin S; Growdon J H
Different cognitive profiles on standard behavioral tests in Parkinson's disease and Alzheimer's disease.
Journal of clinical and experimental neuropsychology 1989;11(6):799-820.
-
1989: de la Monte S M; Wells S E; Hedley-Whyte T; Growdon J H
Neuropathological distinction between Parkinson's dementia and Parkinson's plus Alzheimer's disease.
Annals of neurology 1989;26(3):309-20.
-
1989: Farrer L A; O'Sullivan D M; Cupples L A; Growdon J H; Myers R H
Assessment of genetic risk for Alzheimer's disease among first-degree relatives.
Annals of neurology 1989;25(5):485-93.
-
1989: Phelps C H; Gage F H; Growdon J H; Hefti F; Harbaugh R; Johnston M V; Khachaturian Z S; Mobley W C; Price D L; Raskind M
Potential use of nerve growth factor to treat Alzheimer's disease.
Neurobiology of aging 1989;10(2):205-7.
-
1989: Freed D M; Corkin S; Growdon J H; Nissen M J
Selective attention in Alzheimer's disease: characterizing cognitive subgroups of patients.
Neuropsychologia 1989;27(3):325-39.
-
1988: Sagar H J; Sullivan E V; Gabrieli J D; Corkin S; Growdon J H
Temporal ordering and short-term memory deficits in Parkinson's disease.
Brain : a journal of neurology 1988;111 ( Pt 3)():525-39.
-
1988: Johnson K A; Holman B L; Mueller S P; Rosen T J; English R; Nagel J S; Growdon J H
Single photon emission computed tomography in Alzheimer's disease. Abnormal iofetamine I 123 uptake reflects dementia severity.
Archives of neurology 1988;45(4):392-6.
-
1988: Sagar H J; Cohen N J; Sullivan E V; Corkin S; Growdon J H
Remote memory function in Alzheimer's disease and Parkinson's disease.
Brain : a journal of neurology 1988;111 ( Pt 1)():185-206.
-
1988: Freed D M; Corkin S; Growdon J H; Nissen M J
Selective attention in Alzheimer's disease: CSF correlates of behavioral impairments.
Neuropsychologia 1988;26(6):895-902.
-
1987: Johnson K A; Davis K R; Buonanno F S; Brady T J; Rosen T J; Growdon J H
Comparison of magnetic resonance and roentgen ray computed tomography in dementia.
Archives of neurology 1987;44(10):1075-80.
-
1987: St George-Hyslop P H; Tanzi R E; Polinsky R J; Neve R L; Pollen D; Drachman D; Growdon J; Cupples L A; Nee L; Myers R H
Absence of duplication of chromosome 21 genes in familial and sporadic Alzheimer's disease.
Science (New York, N.Y.) 1987;238(4827):664-6.
-
1987: Huff F J; Growdon J H; Corkin S; Rosen T J
Age at onset and rate of progression of Alzheimer's disease.
Journal of the American Geriatrics Society 1987;35(1):27-30.
-
1987: Cronin-Golomb A; Rho W A; Corkin S; Growdon J H
Abstract reasoning in age-related neurological disease.
Journal of neural transmission. Supplementum 1987;24():79-83.
-
1987: Rosen T J; Growdon J H; Corkin S
Comparison of rates of progression in Alzheimer's disease and Parkinson's disease.
Journal of neural transmission. Supplementum 1987;24():105-7.
-
1987: St George-Hyslop P; Polinsky R; Haines J; Nee L; Tanzi R; Conneally P; Growdon J; Myers R; Pollen D; Drachman D
Search for the familial Alzheimer's disease gene.
Journal of neural transmission. Supplementum 1987;24():13-21.
-
1987: Growdon J H; Corkin S
Cognitive impairments in Parkinson's disease.
Advances in neurology 1987;45():383-92.
-
1986: Miatto O; Gonzalez R G; Buonanno F; Growdon J H
In vitro 31P NMR spectroscopy detects altered phospholipid metabolism in Alzheimer's disease.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1986;13(4 Suppl):535-9.
-
1986: Huff F J; Growdon J H
Neurological abnormalities associated with severity of dementia in Alzheimer's disease.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1986;13(4 Suppl):403-5.
-
1986: Mazurek M F; Growdon J H; Beal M F; Martin J B
CSF vasopressin concentration is reduced in Alzheimer's disease.
Neurology 1986;36(8):1133-7.
-
1986: Huff F J; Corkin S; Growdon J H
Semantic impairment and anomia in Alzheimer's disease.
Brain and language 1986;28(2):235-49.
-
1986: Growdon J H; Corkin S; Huff F J; Rosen T J
Piracetam combined with lecithin in the treatment of Alzheimer's disease.
Neurobiology of aging 1986;7(4):269-76.
-
1986: Growdon J H
Phosphatidylcholine and tardive dyskinesia.
Biological psychiatry 1986;21(7):702-4.
-
1986: Huff F J; Maire J C; Growdon J H; Corkin S; Wurtman R J
Cholinesterases in cerebrospinal fluid. Correlations with clinical measures in Alzheimer's disease.
Journal of the neurological sciences 1986;72(2-3):121-9.
-
1986: Beal M F; Growdon J H; Mazurek M F; Martin J B
CSF somatostatin-like immunoreactivity in dementia.
Neurology 1986;36(2):294-7.
-
1986: Beal M F; Growdon J H
CSF neurotransmitter markers in Alzheimer's disease.
Progress in neuro-psychopharmacology & biological psychiatry 1986;10(3-5):259-70.
-
1985: Lieberman H R; Corkin S; Spring B J; Wurtman R J; Growdon J H
The effects of dietary neurotransmitter precursors on human behavior.
The American journal of clinical nutrition 1985;42(2):366-70.
-
1985: Logue M P; Growdon J H; Coviella I L; Wurtman R J
Differential effects of DSP-4 administration on regional brain norepinephrine turnover in rats.
Life sciences 1985;37(5):403-9.
-
1985: Nissen M J; Corkin S; Buonanno F S; Growdon J H; Wray S H; Bauer J
Spatial vision in Alzheimer's disease. General findings and a case report.
Archives of neurology 1985;42(7):667-71.
-
1985: Gibson C J; Logue M; Growdon J H
CSF monoamine metabolite levels in Alzheimer's and Parkinson's disease.
Archives of neurology 1985;42(5):489-92.
-
1985: Wurtman J; Wurtman R; Mark S; Tsay R; Gilbert W; Growdon J
d-Fenfluramine selectively suppresses carbohydrate snacking by obese subjects.
The International journal of eating disorders 1985;4(1):89-99.
-
1985: Growdon J H; Corkin S; Huff F J
Clinical evaluation of compounds for the treatment of memory dysfunction.
Annals of the New York Academy of Sciences 1985;444():437-49.
-
1985: Sagar H J; Cohen N J; Corkin S; Growdon J H
Dissociations among processes in remote memory.
Annals of the New York Academy of Sciences 1985;444():533-5.
-
1984: Zubenko G S; Cohen B M; Growdon J; Corkin S
Cell membrane abnormality in Alzheimer's disease.
Lancet 1984;2(8396):235.
-
1984: Growdon J H; Wheeler S; Graham H N
Plasma choline responses to lecithin-enriched soup.
Psychopharmacology bulletin 1984;20(3):603-6.
-
1984: Lieberman H R; Corkin S; Spring B J; Garfield G S; Growdon J H; Wurtman R J
The effects of tryptophan and tyrosine on human mood and performance.
Psychopharmacology bulletin 1984;20(3):595-8.
-
1983: Growdon J H
Neuropharmacology of degenerative diseases associated with aging.
Medicinal research reviews 1983;3(3):237-57.
-
1983: Corkin S; Growdon J H; Rasmussen S L
Parental age as a risk factor in Alzheimer's disease.
Annals of neurology 1983;13(6):674-6.
-
1982: Canter N L; Hallett M; Growdon J H
Lecithin does not affect EEG spectral analysis or P300 in Alzheimer disease.
Neurology 1982;32(11):1260-6.
-
1982: Gunne L M; Growdon J H
A model for oral dyskinesia in rats.
Journal of clinical psychopharmacology 1982;2(5):308-11.
-
1982: Myers R H; Growdon J H; Bird E D; Feldman R G; Martin J B
False-negative results with levodopa for early detection of Huntington's disease.
The New England journal of medicine 1982;307(9):561-2.
-
1982: Kosik K H; Growdon J H
Aging, memory loss, and dementia.
Psychosomatics 1982;23(7):745-7, 751.
-
1982: Growdon J H; Melamed E; Logue M; Hefti F; Wurtman R J
Effects of oral L-tyrosine administration on CSF tyrosine and homovanillic acid levels in patients with Parkinson's disease.
Life sciences 1982;30(10):827-32.
-
1982: Lieberman H R; Corkin S; Spring B J; Growdon J H; Wurtman R J
Mood, performance, and pain sensitivity: changes induced by food constituents.
Journal of psychiatric research 1982;17(2):135-45.
-
1982: Gunne L M; Growdon J; Glaeser B
Oral dyskinesia in rats following brain lesions and neuroleptic drug administration.
Psychopharmacology 1982;77(2):134-9.
-
1981: Zeisel S; Reinstein D; Corkin S; Growdon J; Wurtman R
Cholinergic neurones and memory.
Nature 1981;293(5829):187-8.
-
1980: Zeisel S H; Growdon J H; Wurtman R J; Magil S G; Logue M
Normal plasma choline responses to ingested lecithin.
Neurology 1980;30(11):1226-9.
-
1980: Growdon J H; Wurtman R J
Nutrients and neurotransmitters.
New York state journal of medicine 1980;80(10):1638-9.
-
1980: Gelenberg A J; Wojcik J D; Growdon J H; Sved A F; Wurtman R J
Tyrosine for the treatment of depression.
The American journal of psychiatry 1980;137(5):622-3.
-
1980: Brown D R; Growdon J H
L-Tryptophan administration potentiates serotonin-dependent myoclonic behavior in the rat.
Neuropharmacology 1980;19(4):343-7.
-
1980: Growdon J H; Corkin S
Neurochemical approaches to the treatment of senile dementia.
Proceedings of the annual meeting of the American Psychopathological Association 1980;69():281-96.
-
1980: Melamed E; Glaeser B; Growdon J H; Wurtman R J
Plasma tyrosine in normal humans: effects of oral tyrosine and protein-containing meals.
Journal of neural transmission 1980;47(4):299-306.
-
1980: Zeisel S H; Gelenberg A J; Growdon J H; Wurtman R J
Use of choline and lecithin in the treatment of tardive dyskinesia.
Advances in biochemical psychopharmacology 1980;24():463-70.
-
1979: Glaeser B S; Melamed E; Growdon J H; Wurtman R J
Elevation of plasma tyrosine after a single oral dose of L-tyrosine.
Life sciences 1979;25(3):265-71.
-
1979: Gelenberg A J; Doller-Wojcik J C; Growdon J H
Choline and lecithin in the treatment of tardive dyskinesia: preliminary results from a pilot study.
The American journal of psychiatry 1979;136(6):772-6.
-
1979: Growdon J H; Wurtman R J
Dietary influences on the synthesis of neurotransmitters in the brain.
Nutrition reviews 1979;37(5):129-36.
-
1979: Growdon J H
Serotonergic mechanisms in myoclonus.
Journal of neural transmission. Supplementum 1979;(15):209-16.
-
1978: Growdon J H
Effects of choline on tardive dyskinesia and other movement disorders.
Psychopharmacology bulletin 1978;14(4):55-6.
-
1978: Hirsch M J; Growdon J H; Wurtman R J
Relations between dietary choline or lecithin intake, serum choline levels, and various metabolic indices.
Metabolism: clinical and experimental 1978;27(8):953-60.
-
1978: Growdon J H
Changes in motor behavior following the administration of serotonin neurotoxins.
Annals of the New York Academy of Sciences 1978;305():510-23.
-
1978: Growdon J H; Gelenberg A J; Doller J; Hirsch M J; Wurtman R J
Lecithin can suppress tardive dyskinesia.
The New England journal of medicine 1978;298(18):1029-30.
-
1978: Wurtman R J; Growdon J H
Dietary enhancement of CNS neurotransmitters.
Hospital practice 1978;13(3):71-7.
-
1978: Growdon J H; Gelenberg A J
Choline and lecithin administration to patients with tardive dyskinesia.
Transactions of the American Neurological Association 1978;103():95-9.
-
1978: Sahakian B J; Growdon J H; Millington W R; Barr J K; Wurtman R J
The effects of cholinergic agonists on apomorphine-induced stereotyped behavior in the rat.
Communications in psychopharmacology 1978;2(3):255-62.
-
1977: Growdon J H
Postural changes, tremor, and myoclonus in the rat immediately following injections of p-chloromaphetamine.
Neurology 1977;27(11):1074-7.
-
1977: Growdon J H; Hirsch M J; Wurtman R J; Wiener W
Oral choline administration to patients with tardive dyskinesia.
The New England journal of medicine 1977;297(10):524-7.
-
1977: Wurtman R J; Hirsch M J; Growdon J H
Lecithin consumption raises serum-free-choline levels.
Lancet 1977;2(8028):68-9.
-
1977: Growdon J H; Cohen E L; Wurtman R J
Huntington's disease: clinical and chemical effects of choline administration.
Annals of neurology 1977;1(5):418-22.
-
1977: Hirsch M J; Growdon J H; Wurtman R J
Increase in hippocampal acetylcholine after choline administration.
Brain research 1977;125(2):383-5.
-
1977: Growdon J H; Cohen E L; Wurtman R J
Treatment of brain disease with dietary precursors of neurotransmitters.
Annals of internal medicine 1977;86(3):337-9.
-
1977: Growdon J H; Cohen E L; Wurtman R J
Effects of oral choline administration on serum and CSF choline levels in patients with Huntington's disease.
Journal of neurochemistry 1977;28(1):229-31.
-
1976: Growdon J H; Young R R; Shahani B T
L-5-hydroxytryptophan in treatment of several different syndromes in which myoclonus is prominent.
Neurology 1976;26(12):1135-40.
-
1976: Stewart R M; Growdon J H; Cancian D; Baldessarini R J
5-hydroxytryptophan-induced myoclonus: increased sensitivity to serotonin after intracranial 5,7-dihydroxytryptamine in the adult rat.
Neuropharmacology 1976;15(8):449-55.
-
1976: Stewart R M; Growdon J H; Cancian D; Baldessarini R J
Myoclonus after 5-hydroxytryptophan in rats with lesions of indoleamine neurons in the central nervous system.
Neurology 1976;26(7):690-2.
-
1975: Young R R; Growdon J H; Shahani B T
Beta-adrenergic mechanisms in action tremor.
The New England journal of medicine 1975;293(19):950-3.
-
1975: Growdon J H; Shahani B T; Young R R
The effect of alcohol on essential tremor.
Neurology 1975;25(3):259-62.
-
1975: Growdon J H; Young R R; Shahani B T
The differential diagnosis of tremor in Parkinson's disease.
Transactions of the American Neurological Association 1975;100():197-9.
-
1974: Growdon J H; Winkler G F; Wray S H
Midbrain ptosis. A case with clinicopathologic correlation.
Archives of neurology 1974;30(2):179-81.
-
1974: Young R R; Shahani B T; Growdon J H
Beta-adrenergic mechanisms in essential tremor.
Transactions of the American Neurological Association 1974;99():265-7.
-
1973: Goldberger M E; Growdon J H
Pattern of recovery following cerebellar deep nuclear lesions in monkeys.
Experimental neurology 1973;39(2):307-22.
-
1967: Growdon J H; Chambers W W; Liu C N
An experimental study of cerebellar dyskinesia in the rhesus monkey.
Brain : a journal of neurology 1967;90(3):603-32.
Sign-in to see more